Transdermal scopolamine-induced neurologic deficits in patients with cancer.

M. H. Friedberg, Michael Glantz

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)141-142
Number of pages2
JournalRhode Island medicine
Volume77
Issue number5
StatePublished - May 1994

Fingerprint

Cutaneous Administration
Scopolamine Hydrobromide
Neurologic Manifestations
Nervous System Diseases
Nausea
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{92f54b04696844de91524f59109a11a5,
title = "Transdermal scopolamine-induced neurologic deficits in patients with cancer.",
author = "Friedberg, {M. H.} and Michael Glantz",
year = "1994",
month = "5",
language = "English (US)",
volume = "77",
pages = "141--142",
journal = "Rhode Island medicine",
issn = "2327-2228",
publisher = "Rhode Island Medical Society",
number = "5",

}

Transdermal scopolamine-induced neurologic deficits in patients with cancer. / Friedberg, M. H.; Glantz, Michael.

In: Rhode Island medicine, Vol. 77, No. 5, 05.1994, p. 141-142.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transdermal scopolamine-induced neurologic deficits in patients with cancer.

AU - Friedberg, M. H.

AU - Glantz, Michael

PY - 1994/5

Y1 - 1994/5

UR - http://www.scopus.com/inward/record.url?scp=0028437309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028437309&partnerID=8YFLogxK

M3 - Article

C2 - 8019013

AN - SCOPUS:0028437309

VL - 77

SP - 141

EP - 142

JO - Rhode Island medicine

JF - Rhode Island medicine

SN - 2327-2228

IS - 5

ER -